Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 2, No. 1, 2010
Issue release date: January – April
Section title: Published: April 2010

Open Access Gateway

Case Rep Dermatol 2010;2:40–45

Frontal Fibrosing Alopecia: Role of Dermoscopy in Differential Diagnosis

Rubegni P. · Mandato F. · Fimiani M.
Dermatology Unit, Department of Clinical Medicine and Immunological Sciences, University of Siena, Siena, Italy
email Corresponding Author

Dr. Filomena Mandato

Department of Clinical Medicine and Immunological Sciences

Dermatology Unit, Policlinico ‘Le Scotte’, Viale Bracci 1

IT–53100 Siena (Italy)

Tel. +39 0577 585 428, Fax +39 0577 442 38, E-Mail filo24k@yahoo.it

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


Frontal fibrosing alopecia (FFA) is more common in postmenopausal women, but it can occur in younger women. Some authors consider FFA to be a distinct frontal variant of lichen planopilaris. From a clinical point of view, this relatively uncommon condition is characterized by progressive frontotemporal recession due to inflammatory destruction of hair follicles. Dermoscopy can be very useful, as the differential diagnosis between traction alopecia, alopecia areata, FFA and cicatricial marginal alopecia may be difficult. It is not clear whether or not treatment alters the natural history of the disease – the disease stabilized with time in most of the patients with or without continuing treatment. Here we report a case of a 50-year-old woman with FFA and discuss the relevance of dermoscopy in the differential diagnosis of this disease.

© 2010 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Published: April 2010

Published online: April 08, 2010
Issue release date: January – April

Number of Print Pages: 6
Number of Figures: 2
Number of Tables: 1

ISSN: (Print)
eISSN: 1662-6567 (Online)

For additional information: http://www.karger.com/CDE

Open Access License / Drug Dosage / Disclaimer

Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.